November 2019 Price Concessions – 2nd update

November 2019 Price Concessions – 2nd update

November 22, 2019

Department of Health and Social Care (DHSC) has today granted the following list of price concessions:

Drug Pack size Price Concession
Amiloride 5mg tablets 28 £19.50
Bumetanide 1mg tablets 28 £1.95
Co-careldopa 25mg/100mg tablets 100 £11.99
Dexamfetamine 5mg/5ml oral solution sugar free 500 £381.63
Indapamide 2.5mg tablets 28 £2.20
Irbesartan 150mg tablets 28 £6.33
Irbesartan 300mg tablets 28 £6.93
Irbesartan 75mg tablets 28 £3.44
Levetiracetam 1g tablets 60 £12.50
Meloxicam 15mg tablets 30 £5.55
Memantine 10mg tablets 28 £3.30
Nefopam 30mg tablets 90 £7.99
Nifedipine 5mg capsules 90 £51.95
Nifedipne 10mg capsules 90 £65.63
Nitrofurantoin 100mg tablets 28 £10.68
Nizatidine 150mg capsules 30 £7.99
Oxytetracycline 250mg tablets 28 £4.99
Propranolol 10mg tablets 28 £2.00
Propranolol 40mg tablets 28 £2.00
Quinine sulfate 300mg tablets 28 £5.90
Ranitidine 150mg tablets 60 £4.07
Ranitidine 300mg tablets 30 £3.85

DHSC previously (19.11.2019) granted the following price concessions:

Drug Pack size Price Concession
Alverine 60mg capsules 100 £9.25
Cefalexin 125mg/5ml oral suspension 100ml £1.95
Cefalexin 250mg/5ml oral suspension 100ml £2.25
Cyclizine 50mg/1ml solution for injection ampoules 5 £12.56
Hydroxyzine 25mg tablets 28 £1.02
Lamotrigine 100mg dispersible tablets sugar free 56 £9.99
Meloxicam 7.5mg tablets 30 £1.91
Orlistat 120mg capsules 84 £28.49
Venlafaxine 75mg tablets 56 £4.96

No additional endorsements are required for price concessions. A price concession only applies for the month in which it is granted.

PSNC is still working with the DHSC to agree further concessionary prices on other drugs reported to be unavailable at the stated November 2019 Drug Tariff price. Contractors will be alerted to further updates to the price concession list through our website and via our e-news email.  If you wish to subscribe to our email list, you can receive an email as soon as any announcements are made. Please note that PSNC cannot provide details of any generic products awaiting price concession approval from DHSC.

If you have problems obtaining a Part VIII product or problems obtaining the product at the stated Drug Tariff price, please report the issue to PSNC using the online feedback form on the PSNC Website.
Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. PSNC will investigate the extent of the problem and if appropriate discuss the issue with DHSC.



Posted in:


More Latest News >

Metformin Safety Update

The Medicines and Healthcare products Regulatory Agency (MHRA) has been made aware that outside of the UK very low amounts...

PQS: NSAID quality criterion

This news story highlights several points on the non-steroidal anti-inflammatory drug (NSAID) quality criterion of the Pharmacy Quality Scheme (PQS)...